On Hormone Therapy ‘Satisfaction,’ Caution Is Advised
[Editor’s note: This piece originally appeared as a comment in response to Laura Kuper et al.’s “Satisfaction, Regret, and Harm After Hormone Therapy in Youth From a Multidisciplinary Gender Clinic” in JAMA Pediatrics. That article is available here.]
Based on this study one might conclude that satisfaction & lack of regret are paramount to evaluating care of youth with gender dysphoria. The authors claim their results “support … the existing standards of care” & “do not support efforts to … ban access” to cross-sex hormones for minors. That conclusion goes beyond what the data can establish.
First, patient satisfaction measures must be taken with caution. Relevant to all of medicine is Joshua Fenton et al.’s work showing that “higher patient satisfaction was associated with … greater inpatient use, higher overall health care … expenditures, and increased mortality.” Further, Brian Sites et al. conclude that “[a]mong patients with musculoskeletal conditions, those using prescription opioids are more likely to be highly satisfied with their care.” And Kathryn Martinez et al. find that “patients who receive antibiotics for [respiratory tract infections] are more satisfied.”
Simply, satisfaction doesn’t necessarily equal appropriate care.
Read the full piece in JAMA Pediatrics.

